Product Images Journavx
View Photos of Packaging, Labels & Appearance
- Chemical Structure - journavx 01
- Figure 1 - journavx 02
- Figure 2 - journavx 03
- PRINCIPAL DISPLAY PANEL - 50 mg Tablet Bottle Label - journavx 04
- PRINCIPAL DISPLAY PANEL - 50 mg Tablet Bottle Label - NDC 51167-548-31 - journavx 05
- PRINCIPAL DISPLAY PANEL - 50 mg Tablet Blister Pack Carton - journavx 06
- PRINCIPAL DISPLAY PANEL - 50 mg Tablet Blister Pack Carton - Professional Sample - journavx 07
Product Label Images
The following 7 images provide visual information about the product associated with Journavx NDC 51167-548 by Vertex Pharmaceuticals Incorporated, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Chemical Structure - journavx 01
Figure 1 - journavx 02
Mean NPRS data related to Placebo and HB/APAP intervention over time in hours. This information can be used to analyze and compare the pain levels experienced by subjects in the study.*
Figure 2 - journavx 03
This text shows a table displaying the mean NPRS (numeric pain rating scale) for different treatments at various time intervals. The treatments include Placebo and HB/APAP. The table also lists the time intervals in hours. This information can be useful for comparing the effectiveness of the Placebo and HB/APAP treatments in pain management over time.*
PRINCIPAL DISPLAY PANEL - 50 mg Tablet Bottle Label - journavx 04
PRINCIPAL DISPLAY PANEL - 50 mg Tablet Bottle Label - NDC 51167-548-31 - journavx 05
This text contains information about a product that includes 100 tablets for oral use. It also provides guidance to refer to the prescribing information for recommended dosage. The location mentioned is Ave, Boston, MA 02210.*
PRINCIPAL DISPLAY PANEL - 50 mg Tablet Blister Pack Carton - journavx 06
This text appears to be a description of a pharmaceutical product named "JOURNAVX" (suzetrigine) tablets in unit dose packaging. The tablets are for institutional use only and come in a pack of 100 tablets. The product is prescription-only and has a National Drug Code (NDC) of 51167-5648-34. The text also includes some identification numbers and codes related to the product.*
PRINCIPAL DISPLAY PANEL - 50 mg Tablet Blister Pack Carton - Professional Sample - journavx 07
This is a description for JOURNAVX tablets in 50 mg per tablet strength. It is a professional sample and not for sale. The tablets contain suzetrigine as the active ingredient.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
